MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Orthofix Medical Retained Earnings 2011-2026 | OFIX
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -368 M | -276 M | -150 M | 1.25 M | 21 M | 59.4 M | 57.7 M | 87.1 M | 70.4 M | 64.2 M | 62.6 M | 65.4 M | 89.3 M | 149 M | 97.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 149 M | -368 M | 1.96 M |
Quarterly Retained Earnings Orthofix Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -366 M | -343 M | -329 M | -276 M | -247 M | -220 M | -186 M | -150 M | -128 M | -99.1 M | -59.7 M | 1.25 M | 8.31 M | - | 16.5 M | 21 M | 53.8 M | 56 M | 53.6 M | 59.4 M | 59.4 M | 59.4 M | 59.4 M | 57.7 M | 57.7 M | 57.7 M | 57.7 M | 87.1 M | 87.1 M | 87.1 M | 87.1 M | 70.4 M | 70.4 M | 70.4 M | 70.4 M | 64.2 M | 64.2 M | 64.2 M | 64.2 M | 62.6 M | 62.6 M | 62.6 M | 62.6 M | 65.4 M | 65.4 M | 65.4 M | 65.4 M | 73.9 M | 73.9 M | 73.9 M | 73.9 M | 103 M | 115 M | 115 M | 115 M | 72 M | 97.3 M | 97.3 M | 97.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 115 M | -366 M | 13.4 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.26 | 1.87 % | $ 1.66 B |  USA |
 |
Align Technology
ALGN
|
2.48 B | $ 171.34 | 0.43 % | $ 12.8 B | USA |
 |
Apyx Medical Corporation
APYX
|
-89.1 M | $ 3.8 | 3.26 % | $ 156 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 10.92 | 0.78 % | $ 1.64 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
AxoGen
AXGN
|
-307 M | $ 33.75 | -2.0 % | $ 1.55 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.1 | -0.24 % | $ 868 M | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 36.82 | 0.16 % | $ 5.49 K | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 63.03 | 0.33 % | $ 93.3 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 9.45 | 0.85 % | $ 268 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 34.91 | 0.33 % | $ 1.08 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.6 | 2.92 % | $ 37.3 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.7 | 0.73 % | $ 347 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-63.5 M | $ 3.56 | 5.0 % | $ 133 M |  France |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 81.39 | 0.42 % | $ 47.6 B | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.6 | 0.05 % | $ 122 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 87.51 | -0.43 % | $ 11.8 B | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 1.92 | 3.23 % | $ 1.17 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.33 | -2.1 % | $ 719 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Inogen
INGN
|
-176 M | $ 6.4 | 3.06 % | $ 170 M | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 55.64 | 1.11 % | $ 1.63 B | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.0 | 2.52 % | $ 16.9 M | USA |
 |
IRadimed Corporation
IRMD
|
64.2 M | $ 96.7 | 0.49 % | $ 1.23 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 85.4 | -1.67 % | $ 2.97 B | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.93 | -0.81 % | $ 374 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
LENSAR
LNSR
|
-178 M | $ 6.03 | -0.5 % | $ 72.1 M | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.38 | 3.38 % | $ 56.1 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |